Testolone (RAD-140) Ultima Pharmaceuticals

£162.00

Testolone (RAD-140) represents a pioneering non-steroidal selective androgen receptor modulator extensively investigated for muscle and bone tissue research applications across laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Testolone (RAD-140) Ultima Pharmaceuticals
Testolone (RAD-140) Ultima Pharmaceuticals
£162.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Compound Profile: Testolone (RAD-140) Ultima Pharmaceuticals

Testolone (RAD-140) is a non-steroidal selective androgen receptor modulator (SARM) developed by Radius Health for preclinical investigation. This compound demonstrates high binding affinity for androgen receptors whilst exhibiting tissue-selective activity in muscle and bone research models. RAD-140 has become increasingly studied across research laboratories at Stroid UK Shop for its unique androgenic properties without the associated side effects observed with traditional anabolic compounds in preclinical studies.

Laboratory Research Applications

Researchers investigate Testolone for its potential applications in muscle-wasting condition studies and neuroprotective research. The compound shows oral bioavailability in animal models, making it suitable for various experimental protocols. Studies within the broader Testolone research category have examined its effects on lean tissue preservation, bone density modulation, and androgenic selectivity. Laboratory investigations also explore RAD-140’s mechanism of action compared to other compounds in the SARMs research portfolio. Scientists evaluate its pharmacokinetic properties alongside other research molecules from our peptide research collection to understand comparative tissue-selective mechanisms.

Analytical Specifications

RAD-140 Research Parameters
CAS Number 1182367-47-0
Molecular Formula C₂₀H₁₆ClN₅O₂
Molecular Weight 393.83 g/mol
Manufacturer Ultima Pharmaceuticals
Storage Conditions Room temperature, dry environment, protect from light
Mechanism Selective androgen receptor binding with tissue selectivity

Research Compliance Statement

This RAD-140 preparation is manufactured strictly for in-vitro research applications and laboratory analytical studies. Not approved for human consumption, clinical use, or therapeutic applications. Researchers must ensure compliance with local regulations governing research chemical handling and maintain appropriate laboratory safety protocols when conducting studies with this compound.

Related